Gee, Julia M. ORCID: https://orcid.org/0000-0001-6483-2015, Meng, Mei Yee, McClelland, Richard A., Mottram, Huw J., Kyme, Susan R., Finlay, Pauline, Goddard, Lindy, Dutkowski, Carol M., Barrow, Denise, Parson, Walther and Fiegl, Heidi
2015.
A new cell panel to study oestrogen receptor loss in acquired endocrine resistant breast cancer.
Cancer Research
75
(9)
, P3-05-19.
|
|
|
Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Goddard, Lindy, Mottram, Huw James, Burmi, Rajpal, Pumford, Sara L., Dutkowski, Carol M., Barrow, Denise, Hutcheson, Iain Robert, Nicholson, Robert Ian, Ellis, Ian O. and Elvin, Paul
2014.
Increased Ret signalling and impact of vandetanib in acquired tamoxifen resistant breast cancer.
Cancer Research
74
(19)
, 738.
10.1158/1538-7445.AM2014-738
|
|
|
Lazaro, Glorianne, Smith, Chris, Goddard, Lindy, Jordan, Nicola Jane, McClelland, Richard Andrew, Barrett-Lee, Peter, Nicholson, Robert Ian and Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702
2013.
Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response.
Endocrine Related Cancer
20
(5)
, pp. 691-704.
10.1530/ERC-13-0019
|
|
Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Baruha, Bedanta, Smith, Chris, Bellerby, Rebecca, Goddard, Lindy, Jordan, Nicola Jane, Poghosyan, Zaruhi ORCID: https://orcid.org/0000-0003-4966-7618, Nicholson, Robert Ian, Barrett-Lee, Peter and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015
2012.
Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
BMC Cancer
12
, 458.
10.1186/1471-2407-12-458
|
|
|
Hutcheson, Iain Robert, Goddard, Lindy, Barrow, Denise, McClelland, Richard Andrew, Francies, Hayley E., Knowlden, Janice Mary, Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015
2011.
Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
Breast Cancer Research
13
(2)
, R29.
10.1186/bcr2848
|
|
|
Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Nicholson, Robert Ian, Barrow, Denise, Dutkowski, Carol Mary, Goddard, Lindy, Jordan, Nicola J., McClelland, Richard Andrew, Knowlden, Janice Mary, Francies, Hayley E., Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702 and Hutcheson, Iain Robert
2011.
Antihormone induced compensatory signalling in breast cancer: an adverse event in the development of endocrine resistance.
Hormone Molecular Biology and Clinical Investigation
5
(2)
, pp. 67-77.
10.1515/HMBCI.2011.009
|
|
Hutcheson, Iain Robert, Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Barrow, Denise and Nicholson, Robert Ian
2010.
Fulvestrant-induced expression of erbB3 and erbB4 sensitizes ER-positive breast cancer cells to heregulins [Abstract].
Breast Cancer Research
12
(S1)
, P13.
10.1186/bcr2510
|
|
|
Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Jordan, Nicola Jane, Morgan, Liam David ORCID: https://orcid.org/0000-0002-7571-6025, Smith, Christopher, Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Nicholson, Robert
2009.
Adverse features of acquired antihormone resistance and their targeting.
Hiscox, Stephen Edward, Gee, Julia Margaret Wendy and Nicholson, Robert, eds.
Therapeutic Resistance to Anti-Hormonal Drugs in Breast Cancer: New Molecular Aspects and their Potential as Targets,
London:
Springer,
pp. 139-160.
(10.1007/978-1-4020-8526-0_8)
|
|
Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Goddard, Lindy, Jordan, Nicola Jane, Smith, Chris, Harper, Maureen Elaine, Nicholson, Robert Ian and Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015
2008.
Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1 [Abstract].
Breast Cancer Research
10
(S2)
, P34.
10.1186/bcr1918
|
|
|
Jones, Helen E., Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015, Hiscox, Stephen Edward ORCID: https://orcid.org/0000-0003-0105-2702, Rubini, M., Barrow, Denise, Knowlden, Janice Mary, Williams, Sophie E., Wakeling, A. E. and Nicholson, Robert Ian
2004.
Insulin-like growth factor-1 receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells.
Endocrine-Related Cancer
11
(4)
, pp. 793-814.
10.1677/erc.1.00799
|
|
| Jones, Helen E., Barrow, Denise, Dutkowski, Carol, Goddard, Lindy, Smith, Christopher, Harper, Maureen E. and Nicholson, Robert Ian 2001. Effect of an EGF-R selective tyrosine kinase inhibitor and an anti-androgen on LNCaP cells: Identification of divergent growth regulatory pathways. The Prostate 49 (1) , pp. 38-47. 10.1002/pros.1116 |
|
Hepburn, P. J., Glynne-Jones, E., Goddard, Lindy, Gee, Julia Margaret Wendy ORCID: https://orcid.org/0000-0001-6483-2015 and Harper, Maureen Elaine
1995.
Cell proliferation in prostatic carcinoma: comparative analysis of Ki-67, MIB-1 and PCNA.
Histochemical Journal
27
(3)
, pp. 196-203.
10.1007/BF00177586
|
|



Up a level